Correction to: Predicting survival in melanoma patients treated with concurrent targeted- or immunotherapy and stereotactic radiotherapy: Melanoma brain metastases prognostic score (Radiation Oncology, (2020), 15, 1, (135), 10.1186/s13014-020-01558-8)

Jana Schaule; Stephanie G.C. Kroeze; Oliver Blanck; Susanne Stera; Klaus H. Kahl; Falk Roeder; Stephanie E. Combs; David Kaul; An Claes; Markus M. Schymalla; Sonja Adebahr; Franziska Eckert; Fabian Lohaus; Nasrin Abbasi-Senger; Guido Henke; Marcella Szuecs; Michael Geier; Nora Sundahl; Daniel Buergy; Reinhard Dummer; Matthias Guckenberger

ArticleOPEN ACCESS

Correction to: Predicting survival in melanoma patients treated with concurrent targeted- or immunotherapy and stereotactic radiotherapy: Melanoma brain metastases prognostic score (Radiation Oncology, (2020), 15, 1, (135), 10.1186/s13014-020-01558-8)

Schaule J
Kroeze S
Blanck O
et al.

Radiation Oncology

DOI: 10.1186/s13014-020-01708-y

2Citations

11Readers

Abstract

An amendment to this paper has been published and can be accessed via the original article.

Cite

CITATION STYLE

APA

Schaule, J., Kroeze, S. G. C., Blanck, O., Stera, S., Kahl, K. H., Roeder, F., … Guckenberger, M. (2020, December 1). Correction to: Predicting survival in melanoma patients treated with concurrent targeted- or immunotherapy and stereotactic radiotherapy: Melanoma brain metastases prognostic score (Radiation Oncology, (2020), 15, 1, (135), 10.1186/s13014-020-01558-8). Radiation Oncology. BioMed Central Ltd. https://doi.org/10.1186/s13014-020-01708-y

Correction to: Predicting survival in melanoma patients treated with concurrent targeted- or immunotherapy and stereotactic radiotherapy: Melanoma brain metastases prognostic score (Radiation Oncology, (2020), 15, 1, (135), 10.1186/s13014-020-01558-8)

Abstract

Cite

Register to see more suggestions